Enzymes: ACP, CPK, Amylase/Lipase

Acid Phosphatase (ACP)

  • General Characteristics and Concentration

    • When evaluating enzymes, the primary concern is the anatomical location where they are found.

    • The highest concentration of acid phosphatase (ACPACP) is located within the prostate gland.

    • While the greatest concentration is in the prostate, it is present throughout various tissues in the body, including:

      • The spleen.

      • The liver.

      • Red blood cells (RBCsRBCs).

      • Platelets.

      • Bone marrow.

  • Diagnostic Replacement and Modern Usage

    • Acid phosphatase is no longer typically included in a Comprehensive Metabolic Panel (CMPCMP).

    • It has been largely replaced by the Prostate Specific Antigen (PSAPSA) test.

    • The reason for this shift is that PSAPSA is both more sensitive and more specific than acid phosphatase.

    • Acid phosphatase was found to be an "okay" screening tool but often failed to detect prostate cancer until the disease had already metastasized to the bone.

  • Mechanism of Elevation in Malignancy

    • ACPACP levels elevate in instances of osteoclastic activity.

    • When prostate cancer metastasizes to the bone, it triggers increases in osteoclastic activity, which is the specific point at which clinicians would observe an elevation in acid phosphatase levels.

  • Challenges with Prostate Specific Antigen (PSAPSA)

    • While PSAPSA is highly sensitive, its propensity for false positives is a significant downside.

    • Potential causes for false elevations in PSAPSA include:

      • Ejaculation within the last 4848 hours prior to the test.

      • A large bowel movement occurring shortly before the test.

    • Clinical response to elevated PSAPSA:

      • In older males (where this is used as a screening tool), providers may retest PSAPSA after a few months or up to a year, depending on the severity of the elevation.

      • If more information is needed, the patient may be referred for a digital rectal exam (DREDRE), a prostate ultrasound, or a biopsy of the prostate.

  • Current Clinical Significance of ACP

    • Today, acid phosphatase is primarily used for:

      • Checking for the recurrence of prostate cancer.

      • Monitoring a patient's response to treatment.

    • Its clinical significance for initial screening is low; it is mostly associated with prostate cancer only after it has reached the bone (metz to bone).

Creatine Phosphokinase (CPK or CK)

  • General Perspectives

    • Understanding enzymes often involves managing "alphabet soup" (three-letter delineations like CPKCPK, CKCK, ACPACP, etc.).

    • Mastering this topic requires the memorization of these abbreviations and the specific pathologies that lead to their elevation.

  • Isoenzymes Overview

    • Isoenzymes are variations of the same enzyme found in different specific tissues.

    • A lab report typically shows Total CPK.

    • If total CPKCPK is elevated, a follow-up test is needed to break out the isoenzymes. Many labs offer a reflexive order where the isoenzymes are automatically drawn if the total level is high.

    • Clinical determination of the cause of elevation involves using both the isoenzyme sub-fraction and the patient's history.

  • Isoenzyme Categorization and Locations

    • CPK-1 (CPK-BB): Located in the brain.

      • Memory Tool: "One Big Brain" (BBBB).

    • CPK-2 (CPK-MB): Located in the heart and the diaphragm.

      • Memory Tool: "Two muscles that beat" (MBMB).

    • CPK-3 (CPK-MM): Located in the skeletal muscle.

      • Memory Tool: In anatomy, skeletal muscle is often shortened to "mm\text{mm}."

Clinical Significance of CPK Elevations

  • CPK-1 (CPK-BB) Elevations

    • Elevations result from pathologies occurring within the brain.

    • Examples include:

      • Stroke.

      • Traumatic Brain Injury (TBITBI).

      • Cerebral hypoxia.

      • Seizures.

      • Certain neurodegenerative conditions (tending toward slow elevations).

  • CPK-2 (CPK-MB) Elevations

    • The primary concern is Myocardial Infarct (MIMI) or heart attacks.

    • While CPK2CPK-2 is a modern cardiac panel component, it is often compared against troponins.

    • Troponins vs. CPK-2:

      • Troponins are the preferred standard because they elevate more quickly (within approximately 22 hours) and stay elevated longer (for 11 to 22 weeks).

      • CPK2CPK-2 increases more slowly, taking 44 to 66 hours to elevate, and returns to normal more quickly within 22 to 33 days.

    • Clinicians use the "concert of information" from troponins and CPK2CPK-2 (plus other enzymes) to time the onset of the heart attack and determine its severity.

  • CPK-3 (CPK-MM) Elevations

    • CPKCPK is considered the best indicator of skeletal muscle damage.

    • Pathologies include:

      • Muscular Dystrophy: Specifically Duchenne or Becker types.

      • Trauma: Crush injuries, fractures impacting surrounding muscle, or surgical interventions.

      • Prolonged or Intense Exercise: Exercise-induced elevations.

      • Hypothyroidism: Can lead to the death of muscle cells and subsequent elevation.

      • Drug-Induced Myopathy: Pharmaceuticals such as statins can cause muscle damage or increase the risk of rhabdomyolysis.

Rhabdomyolysis

  • Pathophysiology

    • The name signifies "lysis of the muscles."

    • When muscle cells break down, myoglobin is released into the bloodstream and eventually ends up in the urine.

  • Common Clinical Presentation

    • Can occur due to over-exercising (a factor to be aware of in chiropractic settings).

    • Myalgia: Muscle pain typically found in the thighs, low back, and shoulders.

    • Darkened Urine: Often described as "brown" or tea-colored urine due to the presence of myoglobin.

    • Other Symptoms: Fatigue and muscle weakness.

Differential Signs and Symptoms of Myocardial Infarct (MI)

  • Male (Typical Presentation)

    • Chief finding: Intense, crushing chest pain often described as "an elephant sitting on the chest."

    • Radiation pattern: Most commonly to the left arm and sometimes traveling to the jaw.

    • Associated symptoms: Shortness of breath and sweating.

  • Female ("Atypical" or Vague Presentation)

    • Chest pain is much less common and often mild, perceived as a feeling of "tightness" in the chest musculature during deep breaths.

    • Radiation pattern: More common in the neck, jaw, shoulders, and upper back.

    • Systemic/GI findings: Nausea, vomiting, and other GI symptoms.

    • Other findings: Unexplained and severe fatigue, dizziness, and lightheadedness.

  • Clinical Illustration (Case Study)

    • A patient presented with mid-back pain, chest fluttering, and worsening fatigue over a week.

    • A cardiac panel (troponins, CPKCPK, etc.) was normal, and the EKGEKG showed an arrhythmia, though the patient was eventually diagnosed with Hashimoto's.

    • Lesson: Vague symptoms in females must be taken seriously to rule out cardiac involvement.

Muscular Dystrophy

  • Duchenne Muscular Dystrophy

    • More common and more severe.

    • Typical onset: 22 to 55 years of age.

    • Characterized by rapid progression and severe muscle weakness.

  • Becker Muscular Dystrophy

    • Lesser frequency and milder presentation.

    • Typical onset: Between 55 and 2020 years of age.

    • Characterized by slower progression and milder weakness.

  • Clinical Presentation and Diagnostics

    • A muscle biopsy and genetic testing are required to differentiate the two definitively.

    • Common initial signs for both:

      • Delayed motor milestones: Delays in learning to walk, running, or climbing stairs.

      • Gowers Sign: A characteristic maneuver where a child uses their hands to "walk up" their own thighs to stand up from a seated or laying position.

      • Proximal Muscle Weakness: Usually impacts the pelvic girdle first, then moves to the shoulders.

      • Gait issues: Widened or waddling gait, clumsiness, and frequent falling.

Amylase and Lipase

  • Functional Roles

    • Amylase: Responsible for breaking down carbohydrates.

    • Lipase: Responsible for breaking down lipids (fats).

  • Anatomical Locations

    • Amylase is found in the pancreas and the salivary glands.

    • Lipase is primarily found in the pancreas and is considered more specific to the pancreas than amylase.

  • Acute Pancreatitis

    • Characterized by reliable elevations in both amylase and lipase.

    • Clinical symptoms:

      • Severe, sudden, and constant epigastric pain.

      • Radiation of pain: Often "boring" through to the back or appearing as a "band-like" pain around the flank.

      • Exacerbating factors: Pain is worse after eating and worse when laying flat.

      • Other symptoms: Nausea, vomiting, fatigue, and fever.

  • Pancreatic Carcinoma

    • Elevations in amylase and lipase are not reliable; the disease must be severe before elevations occur.

    • Symptoms: Epigastric pain radiating to the back, and the potential development of diabetes.

    • Red Flags: Weight loss and severe fatigue should be monitored.

  • Other Causes for Elevation

    • Mumps or inflammation of the salivary glands will lead to elevations in amylase specifically, because of its presence in salivary tissue.

  • Imaging Modalities for Pancreas

    • A CT scan is the preferred starting modality if acute pancreatitis or pancreatic carcinoma is suspected.

    • An MRI may follow after the initial CTCT.